205318-52-1 Usage
Uses
Used in Pharmaceutical Research and Development:
3-(AMINOMETHYL)-1-N-BOC-ANILINE is used as a building block for the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its protective BOC group allows for selective reactions and the creation of complex molecular structures.
Used in Agrochemicals:
In the agrochemical industry, 3-(AMINOMETHYL)-1-N-BOC-ANILINE is used as an intermediate for the preparation of agrochemicals, such as pesticides and herbicides, to enhance crop protection and yield.
Used in Specialty Chemicals:
3-(AMINOMETHYL)-1-N-BOC-ANILINE is utilized as a key intermediate in the synthesis of specialty chemicals, which are used in various applications, including coatings, adhesives, and polymers, due to its ability to be modified with different functional groups.
Used in Organic Synthesis:
As a reagent in organic synthesis, 3-(AMINOMETHYL)-1-N-BOC-ANILINE is employed for the synthesis of new chemical entities and drug candidates, playing a crucial role in the discovery and development of novel compounds with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 205318-52-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,3,1 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 205318-52:
(8*2)+(7*0)+(6*5)+(5*3)+(4*1)+(3*8)+(2*5)+(1*2)=101
101 % 10 = 1
So 205318-52-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H18N2O2/c1-12(2,3)16-11(15)14-10-6-4-5-9(7-10)8-13/h4-7H,8,13H2,1-3H3,(H,14,15)
205318-52-1Relevant articles and documents
Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture
Nasim, Shama,Guzman, Monica L.,Jordan, Craig T.,Crooks, Peter A.
, p. 4879 - 4883 (2011/09/16)
4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) was previously identified as an antileukemic agent exhibiting no evident toxicity toward normal hematopoietic cells. An SAR study has been carried out to examine the effect of varying the C-2 and
RHO KINASE INHIBITORS
-
Page/Page column 83-84, (2008/12/07)
Substituted amide and urea derivatives useful as inhibitors of Rho kinase are described, which inhibitors can be useful in the treatment of various disorders such as cardiovascular diseases, cancer, neurological diseases, renal diseases, bronchial asthma, erectile dysfunction and glaucoma.